Filing Details
- Accession Number:
- 0001237899-13-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-07 10:02:51
- Reporting Period:
- 2013-01-04
- Filing Date:
- 2013-01-07
- Accepted Time:
- 2013-01-07 10:02:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225474 | L Joseph Goldstein | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-04 | 2,260 | $33.42 | 2,260 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-04 | 2,260 | $181.22 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-01-04 | 2,740 | $33.42 | 2,740 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-04 | 2,740 | $180.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-04 | 2,260 | $0.00 | 2,260 | $33.42 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-04 | 2,740 | $0.00 | 2,740 | $33.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,740 | 2021-01-03 | No | 4 | M | Direct | |
| 5,000 | 2021-01-03 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 2,260 shares of Company stock on January 4, 2013 at prices ranging from $181.09 to $181.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 4, 2013 at each separate price.
- Represents volume-weighted average price of sales of 2,740 shares of Company stock on January 4, 2013 at prices ranging from $180.10 to $180.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 4, 2013 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
